| Article Šoštarić et al. 2022 International Journal of Molecular Sciences I Matak, P Šoštarić Medicinski fakultet, 2024 | | 2024 |
| Article Šoštarić et al. 2024 European Journal of Pharmacology I Matak, P Šoštarić Medicinski fakultet, 2024 | | 2024 |
| Article Fabris et al. 2023 JCI Insight-UZSM contribution I Matak, P Meglić, P Šoštarić Medicinski fakultet Sveučilišta u Zagrebu, 2024 | | 2024 |
| Motorički učinci klostridijskih neurotoksina u središnjem živčanom sustavu (MEFCLO)-plan upravljanja istraživačkim podacima I Matak | | 2024 |
| Botulinum toxin type a antinociceptive activity in trigeminal regions involves central transcytosis D Nemanić, M Mustapić, I Matak, L Bach-Rojecky European journal of pharmacology 963, 176279, 2024 | 1 | 2024 |
| Beyond neuromuscular activity: botulinum toxin type A exerts direct central action on spinal control of movement P Šoštarić, M Matić, D Nemanić, ŽL Vasić, M Cifrek, M Pirazzini, I Matak European journal of pharmacology 962, 176242, 2024 | 2 | 2024 |
| Experimental parkinsonism induced by tetanus toxin injected into basal ganglia P Meglic, P Sostaric, N Habek, D Virag, A Knezovic, I Matak bioRxiv, 2024.05. 09.593282, 2024 | | 2024 |
| Botulinum Neurotoxin Type A Regulates Spinal Premotor Inputs Participating in Normal Locomotion and Experimental Spasticity in Rats I Matak, P Šoštarić Toxicon 237, 107453, 2024 | | 2024 |
| Tetanus Toxin–Evoked Disinhibition of the Rat Basal Ganglia Induces Motor Impairments Consistent With Parkinsonism P Meglić, P Šoštarić, I Matak Toxicon 237, 107457, 2024 | | 2024 |
| Botulinum Neurotoxin Type A Antinociceptive Activity in Spinal Cord and Trigeminal Sensory Nociceptive Nuclei Involves Central Trans-Synaptic Transport D Nemanić, L Bach-Rojecky, I Matak Toxicon 237, 107463, 2024 | | 2024 |
| Double-Edged Sword: Challenging the Botulinum Neurotoxin Type A Peripheral vs Central Effects on Muscle Function P Šoštarić, P Meglić, I Matak Toxicon 237, 107493, 2024 | | 2024 |
| Facial Neuromuscular Junctions and Selected Brainstem Nuclei Are the Targets of Tetanus Neurotoxin in Cephalic Tetanus F Fabris, S Varani, M Tonnellato, I Matak, P Šostaric, P Meglic, ... Toxicon 237, 107398, 2024 | | 2024 |
| LOW DOSE TETANUS TOXIN INJECTIONS INTO THE RAT BASAL GANGLIA IMPAIR MOTOR PERFORMANCE P Meglić, P Šoštarić, I Matak IBRO Neuroscience Reports 15, S697-S698, 2023 | | 2023 |
| INVESTIGATING THE LONG-LASTING EFFECTS OF BOTULINUM TOXIN TYPE A ON MOTOR PERFORMANCE AND ATROPHY P Šoštarić, P Meglić, I Matak IBRO Neuroscience Reports 15, S717-S718, 2023 | | 2023 |
| Facial neuromuscular junctions and brainstem nuclei are the target of tetanus neurotoxin in cephalic tetanus F Fabris, S Varani, M Tonellato, I Matak, P Šoštarić, P Meglić, M Caleo, ... JCI insight 8 (11), 2023 | 3 | 2023 |
| The safety of botulinum neurotoxin type A's intraarticular application in experimental animals AD Okroša, VRM Munoz-Lora, I Matak, L Bach-Rojecky, M Kalinichev, ... Toxicon: X 18, 100155, 2023 | | 2023 |
| Botulinum toxin type A impairs spinal control of movement following its axonal transport and transcytosis P Šoštarić, M Matić, D Vađunec, ZL Vasic, M Cifrek, M Pirazzini, I Matak Authorea Preprints, 2023 | | 2023 |
| Lasting peripheral and central effects of botulinum toxin type A on experimental muscle hypertonia in rats P Šoštarić, B Vukić, L Tomašić, I Matak International journal of molecular sciences 23 (19), 11626, 2022 | 11 | 2022 |
| Botulinum toxin: From the natural cause of botulism to an emerging therapeutic in veterinary medicine P Šoštarić, E Članjak–Kudra, A Smajlović, I Matak Veterinaria 71 (2), 153-173, 2022 | | 2022 |
| Characterization of Botulinum Neurotoxin Type A Local Muscular vs Antispastic Action in Rats P Sostaric, M Matic, M Pirazzini, I Mataka TOXICON 214, S50-S50, 2022 | | 2022 |
Zdravko LackovicProfesor farmakologije, Sveučilište u Zagrebu Medicinski fakultet在 mef.hr 的电子邮件经过验证
